Patients, N (%) | 77 |
Age (years), median (min–max) | 70 (24–89) |
Sex: female:male, N (%) | 50 (64.9):27 (35.1) |
Charlson comorbidity index | |
 1–3 | 32 (41.5) |
 4–6 | 30 (39) |
 7–10 | 15 (19.5) |
Disease characteristics | |
 Bleeding as first symptom of disease | 32 (41.6) |
 Recurrent disease, N (%) | 22 (28.2) |
Treatment characteristics | |
 Dose, median (min–max) | 39.0 Gy (9–84.4) |
 Chemotherapy, prior to acute bleeding symptomatic (N (%)) | 30 (39.0) |
 Immunotherapy, any (N (%)) | 2 (2.6) |